243 results on '"Huvila, Jutta"'
Search Results
2. Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signatures
3. Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer
4. External validation of a deep learning-based algorithm for detection of tall cells in papillary thyroid carcinoma: A multicenter study
5. Molecular pathology of endometrial cancer: recent advances in classification, prognostication, and management
6. Asparaginase-like protein 1 as a prognostic tissue biomarker in clinicopathologically and molecularly characterized endometrial cancer
7. Is it safe to operate selected low-risk endometrial cancer patients in secondary hospitals?
8. STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?
9. Endometrial Pipelle Biopsy Computer-Aided Diagnosis: A Feasibility Study
10. A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids
11. Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach
12. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
13. Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death
14. Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer
15. An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
16. Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma
17. Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique
18. Importance of the criteria used for assessment of lymphovascular space invasion in endometrial carcinoma.
19. Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification
20. Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases
21. Combined expression of HOXA11 and CD10 identifies endometriosis versus normal tissue and tumors
22. p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification
23. Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier
24. The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types
25. The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study
26. Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics.
27. p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns
28. Abstract PR002: Proteomic profiling of endometrial carcinomas
29. Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study
30. Endometrial Pipelle biopsy computer-aided diagnosis (ENDO-AID): a feasibility study
31. Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma
32. Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype
33. Corrigendum to “Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death”: [Modern Pathology 36 (2023) 100085]
34. Abstract 6417: Deciphering aberrant STING pathway and exploring oncolytic viruses therapy in low grade serous ovarian carcinoma
35. Abstract 5779: A platform utilizing high-grade serous ovarian cancer organoids for prospective patient stratification in functional precision medicine
36. Supplementary figure 1 from Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas—an ENITEC Group Initiative
37. Supplementary figure 2 from Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas—an ENITEC Group Initiative
38. Supplementary figure 4 from Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas—an ENITEC Group Initiative
39. Supplementary figure 3 from Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas—an ENITEC Group Initiative
40. Supplementary methods from Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas—an ENITEC Group Initiative
41. Supplementary data from Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas—an ENITEC Group Initiative
42. Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma
43. Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study
44. The continuing evolution of endometrial carcinoma molecular classification: Risk stratification within the No Specific Molecular Profile (NSMP) subtype
45. Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer
46. EP114/#506 Molecular classification of endometrial carcinosarcoma shows uniformly P53ABN subtype and provide opportunities for diagnostic improvement
47. 37/#877 Hormonal biomarkers remain prognostic relevant within the molecular classification in endometrial cancer
48. Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways
49. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study
50. The proteome of clear cell ovarian carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.